European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas

European drugmakers on Monday announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums. Anglo-Swedish AstraZeneca AZN, +1.42%   AZN, -1.26% said it’s pay...

Netflix, Workday, Costco, Caterpillar and more: These stocks are Cowen’s favorites for 2023

Across the market, Cowen & Co. analysts see undervalued stocks. They rolled out their individual best picks late in the week, highlighting their takes on compelling plays in healthcare, technology...